These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 16054733)

  • 41. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunogenicity of an inactivated hepatitis A vaccine in infants and young children.
    Bell BP; Negus S; Fiore AE; Plotnik J; Dhotre KB; Williams J; Shapiro CN; McMahon BJ
    Pediatr Infect Dis J; 2007 Feb; 26(2):116-22. PubMed ID: 17259872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing live attenuated and inactivated hepatitis A vaccines: an immunogenicity study after one single dose.
    Zheng H; Chen Y; Wang F; Gong X; Wu Z; Miao N; Zhang X; Li H; Chen C; Hou X; Cui F; Wang H
    Vaccine; 2011 Nov; 29(48):9098-103. PubMed ID: 21875638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine.
    Bovier PA; Bock J; Ebengo TF; Frösner G; Glaus J; Herzog C; Loutan L
    J Med Virol; 2010 Oct; 82(10):1629-34. PubMed ID: 20827757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunogenicity of experimentally combined hepatitis A and hepatitis E vaccine at different dosage ratio].
    Dong C; Dai X; Meng JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):130-3. PubMed ID: 17286906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Vaccination against hepatitis A].
    Giusti G; Russo M
    Recenti Prog Med; 1992 Jun; 83(6):313-20. PubMed ID: 1323136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term Serologic Follow-up of Children Vaccinated with a Pediatric Formulation of Virosomal Hepatitis A Vaccine Administered With Routine Childhood Vaccines at 12-15 Months of Age.
    Dagan R; Ashkenazi S; Livni G; Go O; Bagchi P; Sarnecki M
    Pediatr Infect Dis J; 2016 Jul; 35(7):e220-8. PubMed ID: 27093164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative antigenic activity of the hepatitis A inactivated vaccine among military personnel].
    Shumilov VI; Shevtsov VA; Lobastov SP; Salmina TA; Shervarli VI; Vardanian NV; Nikolaeva EI
    Voen Med Zh; 2004 Jan; 325(1):62-5. PubMed ID: 15038272
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
    Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
    Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis A and vaccination.
    Teuwen DE
    Arch Inst Pasteur Tunis; 1994; 71(3-4):549-56. PubMed ID: 8801857
    [No Abstract]   [Full Text] [Related]  

  • 51. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence.
    Van Herck K; Van Damme P
    J Med Virol; 2001 Jan; 63(1):1-7. PubMed ID: 11130881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The investigation on the safety and immunogenicity of inactived hepatitis A vaccine AVAXIM].
    Huang G; Wan Z; Li R
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):287-8. PubMed ID: 11860802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis A vaccine.
    Med Lett Drugs Ther; 1995 Jun; 37(950):51-2. PubMed ID: 7760768
    [No Abstract]   [Full Text] [Related]  

  • 54. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence.
    Van Damme P; Thoelen S; Cramm M; De Groote K; Safary A; Meheus A
    J Med Virol; 1994 Dec; 44(4):446-51. PubMed ID: 7897379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune responses of anti-HAV in children vaccinated with live attenuated and inactivated hepatitis A vaccines.
    Wang XY; Xu Z; Yao X; Tian M; Zhou L; He L; Wen Y
    Vaccine; 2004 May; 22(15-16):1941-5. PubMed ID: 15121306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis A booster vaccine in children after infant immunization.
    Kanra G; Yalcin SS; Kara A; Ozmert E; Yurdakök K
    Pediatr Infect Dis J; 2002 Aug; 21(8):727-30. PubMed ID: 12192159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A single dose of inactivated hepatitis A vaccine promotes HAV-specific memory cellular response similar to that induced by a natural infection.
    Melgaço JG; Morgado LN; Santiago MA; Oliveira JM; Lewis-Ximenez LL; Hasselmann B; Cruz OG; Pinto MA; Vitral CL
    Vaccine; 2015 Jul; 33(32):3813-20. PubMed ID: 26144899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Active immunization against hepatitis A. Comparison of various immunization schedules].
    Müller R; Bock HL; Clemens R; Jilg W
    Dtsch Med Wochenschr; 1993 Aug; 118(31):1101-4. PubMed ID: 8393760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up study.
    Yu C; Song Y; Qi Y; Li C; Jiang Z; Li C; Zhang W; Wang L; Xia J
    Hum Vaccin Immunother; 2016 Oct; 12(10):2595-2602. PubMed ID: 27385349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.